Induction gefitinib followed by standard chemoradiotherapy in locally advanced (LA) non-small cell lung cancer (NSCLC) with epidermal growth factor receptor (EGFR) activating mutations: The LOGIK0902/OLCSG0905 intergroup phase II study

Saved in:

Bibliographic Details
Published in	Annals of oncology Vol. 30; p. ix153
Main Authors	Saeki, S., Hotta, K., Yamaguchi, M., Harada, D., Bessho, A., Tanaka, K., Inoue, K., Gemba, K., Ichihara, E., Kishimoto, J., Sasaki, T., Shioyama, Y., Katsui, K., Sasaki, J., Kiura, K., Sugio, K.
Format	Journal Article
Language	English
Published	01.11.2019
Online Access	Get full text

Loading…

More Information
ISSN:	0923-7534
DOI:	10.1093/annonc/mdz436